Purification of cyclotron-produced 203Pb for labeling Herceptin
- 7 April 2005
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (3) , 301-305
- https://doi.org/10.1016/j.nucmedbio.2004.11.004
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the α-emitting radionuclides 212Bi or 211AtNuclear Medicine and Biology, 2004
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic ApplicationsChemical Reviews, 2001
- Targeted therapy using alpha emittersPhysics in Medicine & Biology, 1996
- Convenient synthesis of bifunctional tetraaza macrocyclesBioconjugate Chemistry, 1992
- The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapyGynecologic Oncology, 1989
- The production of carrier-free lead-203The International Journal of Applied Radiation and Isotopes, 1982
- Production of 201Tl and 203Pb via proton induced nuclear reactions on natural thalliumThe International Journal of Applied Radiation and Isotopes, 1979
- Human colonic adenocarcinoma cellsIn Vitro Cellular & Developmental Biology - Plant, 1976
- Metabolic Characteristics Within a Chemical FamilyHealth Physics, 1959